Open Access. Powered by Scholars. Published by Universities.®
Department of Medical Oncology Faculty Papers
Allele; Article; blood analysis; breast metastasis; cancer growth; cancer patient; cancer tissue; cell clone; cell isolation; circulating tumor cell; cloning; controlled study; exon; gene amplification; gene cluster; gene deletion; gene mutation; gene sequence; genetic marker; human; human tissue; immunohistochemistry; skin biopsy; triple negative breast cancer; tumor biopsy; wild type
Articles 1 - 1 of 1
Full-Text Articles in Entire DC Network
Tp53 Mutations Detected In Circulating Tumor Cells Present In The Blood Of Metastatic Triple Negative Breast Cancer Patients., Sandra V Fernandez, Catherine Bingham, Patricia Fittipaldi, Laura Austin, Juan P. Palazzo, Gary Palmer, Katherine Alpaugh, Massimo Cristofanilli
Tp53 Mutations Detected In Circulating Tumor Cells Present In The Blood Of Metastatic Triple Negative Breast Cancer Patients., Sandra V Fernandez, Catherine Bingham, Patricia Fittipaldi, Laura Austin, Juan P. Palazzo, Gary Palmer, Katherine Alpaugh, Massimo Cristofanilli
Department of Medical Oncology Faculty Papers
INTRODUCTION: Circulating tumor cells (CTCs) are tumor cells shed from either primary tumors or its metastases that circulate in the peripheral blood of patients with metastatic cancers. The molecular characterization of the CTCs is critical to identifying the key drivers of cancer metastasis and devising therapeutic approaches. However, the molecular characterization of CTCs is difficult to achieve because their isolation is a major technological challenge.
METHODS: CTCs from two triple negative breast cancer patients were enriched using CellSearch and single cells selected by DEPArray™. A TP53 R110 fs*13 mutation identified by next generation sequencing in the breast and chest skin …